These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 30539697
1. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats. Zheng R, Fang X, He L, Shao Y, Guo N, Wang L, Liu M, Li D, Geng H. Curr Mol Med; 2018; 18(7):436-447. PubMed ID: 30539697 [Abstract] [Full Text] [Related]
2. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene. Li Y, Zheng R, Xu G, Huang Y, Li Y, Li D, Geng H. Am J Physiol Renal Physiol; 2021 Mar 01; 320(3):F475-F484. PubMed ID: 33491567 [Abstract] [Full Text] [Related]
3. CRISPR/Cas9-mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1. Zheng R, Li Y, Wang L, Fang X, Zhang J, He L, Yang L, Li D, Geng H. Kidney Int; 2020 Oct 01; 98(4):947-957. PubMed ID: 32464217 [Abstract] [Full Text] [Related]
4. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology. Estève J, Blouin JM, Lalanne M, Azzi-Martin L, Dubus P, Bidet A, Harambat J, Llanas B, Moranvillier I, Bedel A, Moreau-Gaudry F, Richard E. Biochem Biophys Res Commun; 2019 Oct 01; 517(4):677-683. PubMed ID: 31402115 [Abstract] [Full Text] [Related]
5. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1. Kukreja A, Lasaro M, Cobaugh C, Forbes C, Tang JP, Gao X, Martin-Higueras C, Pey AL, Salido E, Sobolov S, Subramanian RR. Nucleic Acid Ther; 2019 Apr 01; 29(2):104-113. PubMed ID: 30676254 [Abstract] [Full Text] [Related]
15. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I. Zabaleta N, Barberia M, Martin-Higueras C, Zapata-Linares N, Betancor I, Rodriguez S, Martinez-Turrillas R, Torella L, Vales A, Olagüe C, Vilas-Zornoza A, Castro-Labrador L, Lara-Astiaso D, Prosper F, Salido E, Gonzalez-Aseguinolaza G, Rodriguez-Madoz JR. Nat Commun; 2018 Dec 21; 9(1):5454. PubMed ID: 30575740 [Abstract] [Full Text] [Related]
17. Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa. Nagara M, Tiar A, Ben Halim N, Ben Rhouma F, Messaoud O, Bouyacoub Y, Kefi R, Hassayoun S, Zouari N, Ben Ammar MS, Abdelhak S, Chemli J. Gene; 2013 Sep 15; 527(1):316-20. PubMed ID: 23810941 [Abstract] [Full Text] [Related]
18. A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type 1: lack of relationship between genotype, enzymic phenotype, and disease severity. Hoppe B, Danpure CJ, Rumsby G, Fryer P, Jennings PR, Blau N, Schubiger G, Neuhaus T, Leumann E. Am J Kidney Dis; 1997 Jan 15; 29(1):36-44. PubMed ID: 9002528 [Abstract] [Full Text] [Related]
19. Multiplex gene editing reduces oxalate production in primary hyperoxaluria type 1. Zheng R, Zhang DX, Shao YJ, Fang XL, Yang L, Huo YN, Li DL, Geng HQ. Zool Res; 2023 Nov 18; 44(6):993-1002. PubMed ID: 37759334 [Abstract] [Full Text] [Related]